Drew Wightman is an experienced corporate finance and M&A professional currently serving as the Head of Deal Finance & M&A (Oncology, V&I) at AstraZeneca, a role they began in 2025 after previously holding the position of Senior Director from 2015 to 2022. They have a strong background in structuring, negotiating, and executing M&A and business development transactions, with notable accomplishments including high-value acquisitions and collaborations within the life sciences sector. Prior to their tenure at AstraZeneca, Drew worked as a Managing Director in Investment Banking at Alantra and as an Assistant Director at Ernst & Young. Drew earned a BSc (Hons) in Management from Manchester Business School and an MSc in Finance from the University of York, in addition to becoming an ACA certified professional.
This person is not in the org chart
This person is not in any teams
This person is not in any offices